tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Subsidiary Faces Temporary Drug License Suspension in Karnataka

Story Highlights
  • MedPlus Health Services Ltd. operates a vast network of pharmacy outlets in India.
  • A subsidiary’s store in Karnataka faces a one-day drug license suspension, risking revenue loss.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
MedPlus Subsidiary Faces Temporary Drug License Suspension in Karnataka

TipRanks Cyber Monday Sale

MedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has provided an update.

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a one-day suspension order for a drug license at a store located in Alnavara, Karnataka. This suspension, issued under the Drugs and Cosmetics Act, 1940, and related rules, is expected to result in a potential revenue loss of approximately Rs 0.33 Lacs, impacting the company’s financial operations.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmacy retail services. The company is known for its extensive network of pharmacy outlets across India, catering to a wide range of healthcare needs.

Average Trading Volume: 21,238

Technical Sentiment Signal: Hold

Current Market Cap: 91.89B INR

See more data about MEDPLUS stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1